देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
midazolam, Quantity: 15 mg
Accord Healthcare Pty Ltd
Midazolam
Injection, solution
Excipient Ingredients: water for injections; hydrochloric acid; sodium chloride; sodium hydroxide
Intramuscular, Intravenous
Pack of 1 ampoule, 5 Ampoules and 10 Ampoules
(S4) Prescription Only Medicine
? IV as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic;,? IV for induction of anaesthesia, preliminary to administration of other anaesthetic agents. With the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time.,? IV for sedation in intensive care units; intermittent administration or continuous infusion.,? IM for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.
Visual Identification: Clear, colourless to pale yellow, sterile, isotonic, preservative-free solution in clear glass ampoules (type - 1).; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 48 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-05-16